Clinical trial
Lipid Peroxidation and Options Antioxidant Therapy for Secondary Lymphedema of the Lower Extremities
NCT04360889 is registered in ClinicalTrials.gov with Ryazan State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lipid Peroxidation and Options Antioxidant Therapy for Secondary Lymphedema of the Lower Extremities
- Lead sponsor
- Ryazan State Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 1, 2019
- Completion date
- August 3, 2022
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lower extremity lymphedema